================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   ----------

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

       Date of report (Date of earliest event reported) February 15, 2007

                          VARIAN MEDICAL SYSTEMS, INC.
             ------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)

            Delaware                       1-7598                94-2359345
  ----------------------------          ------------         -------------------
  (State or Other Jurisdiction          (Commission            (IRS Employer
        of Incorporation)               File Number)         Identification No.)

            3100 Hansen Way, Palo Alto, CA                      94304-1030
       ----------------------------------------                ------------
       (Address of Principal Executive Offices)                 (Zip Code)

        Registrant's telephone number, including area code (650) 493-4000

                                 Not Applicable
          -------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ]  Written communications pursuant to Rule 425 under the Securities
     Act (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange
     Act (17 CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

================================================================================



Item 5.02.  Departure of Directors or Certain Officers; Election of Directors;
            Appointment of Certain Officers; Compensatory Arrangement of Certain
            Officers.

         On February 15, 2007, the stockholders of Varian Medical Systems, Inc.
(the "Company") at the 2007 Annual Meeting of Stockholders elected Mark R. Laret
as a director of the Company with a term expiring at the 2010 Annual Meeting of
Stockholders. Mr. Laret replaces Mr. Samuel Hellman, who did not stand for
re-election and retired from the Board of Directors of the Company (the "Board")
as of the 2007 Annual Meeting of Stockholders.

         Mr. Laret, age 53, has been CEO of the UCSF Medical Center since April
2000. Prior to that, he was CEO of the UC Irvine Medical Center from 1995 to
March 2000 and served at the UCLA Medical Center from 1980 to 1995 in various
marketing, business development, and management positions including CEO of the
900-physician UCLA Medical Group. Laret earned a masters degree in political
science at the University of Southern California in 1979 and a bachelor's degree
in political science at the University of California at Los Angeles in 1976.

         Mr. Laret currently does not sit on the board of directors of any other
publicly traded company. He will serve on the Board's Nominating and Corporate
Governance Committee. Pursuant to the Company's Second Amended and Restated 2005
Omnibus Stock Plan, Mr. Laret received a grant of non-qualified options for
16,000 shares of the Company's Common Stock and a grant of 4,000 deferred stock
units upon his election.

         On February 20, 2007, Company issued a press release regarding Mark
R. Laret Elected to Board of Directors for Varian Medical Systems. A copy of the
press release is attached as Exhibit 99.1 and incorporated herein by reference.

Item 9.01.  Financial Statements and Exhibits.

       (d)  Exhibits.

            99.1 Press Release dated Febuary 20, 2007 entitled "Mark R. Laret
     Elected to Board of Directors for Varian Medical Systems."



                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                            Varian Medical Systems, Inc.


                                            By:    /s/ John W. Kuo
                                                   -----------------------------
                                            Name:  John W. Kuo
                                            Title: Corporate Vice President,
                                                   General Counsel and Secretary

Dated:  February 20, 2007



                                  EXHIBIT INDEX


 Number                                    Exhibit
 ------        -----------------------------------------------------------------
  99.1         Press Release dated February 20, 2007 regarding Mark R. Laret
               Elected to Board of Directors for Varian Medical Systems.